Director: Theresa Strong
Website - http://www.uab.edu/vector/
ContactDavid Dion, PhD email@example.comThe goal of the UAB Vector Production Facility (VPF) is to accelerate the translation of novel viral vector-based therapies into Phase I trials in patients. Through the production of large-scale research and clinical grade vectors using Good Laboratory and current Good Manufacturing Practices, we assist investigators who wish to conduct FDA-directed safety and toxicity studies, submit investigational new drug (IND) applications and perform early stage clinical trials. We are also experienced in the production of cell banks, recombinant proteins and antibody conjugates for research and clinical applications.